Latest News

Judo Capital Holdings Limited has reported its half-year results for the period ended December 31, 2025, with net interest income rising to A$235.5 million and net profit reaching A$59.9 million, both higher than the prior corresponding period. The uplift in both basic and diluted earnings per share from continuing operations suggests improving profitability as the bank scales its SME-focused lending model. We will now examine how this earnings uplift, particularly the increase in net...

United Laboratories International Holdings (SEHK:3933) and Novo Nordisk have reported Phase 2 data for obesity drug UBT251 in China, with plans to move into Phase 3 locally and to expand global studies. See our latest analysis for United Laboratories International Holdings. The Phase 2 obesity data arrives at a time when the share price has a HK$12.63 latest close and a 3 year total shareholder return above 200%. However, the 1 year total shareholder return of about a 5% decline suggests...

La-Z-Boy (LZB) is back in focus after quarterly results that topped Wall Street expectations on revenue and non GAAP profit, yet drew a negative stock reaction as investors weighed demand uncertainty and fresh tariff risks. See our latest analysis for La-Z-Boy. At a share price of US$35.92, La-Z-Boy has seen short term pressure, with a 30 day share price return of 6.26% decline and a 1 year total shareholder return of 19.43% decline, even though the 3 year total shareholder return sits at...

Protagonist Therapeutics (PTGX) is back in focus after fourth quarter results showed a net loss of US$44.38 million and missed revenue expectations, marking a shift from net income in the prior year period. See our latest analysis for Protagonist Therapeutics. Despite the disappointing quarter, Protagonist Therapeutics' share price has held relatively firm in the short term. It has a 7 day share price return of 4.95% and a 30 day share price return of 5.83%. Its 1 year total shareholder...

SBA Communications recently prepared to report earnings that analysts expect to show lower earnings per share than last year but higher revenues, with particular strength anticipated in international site leasing and development, while its CEO Brendan Cavanagh also spoke at Deutsche Bank’s 34th Annual Media, Internet and Telecom Conference in Palm Beach. This combination of shifting earnings expectations and emphasis on international growth priorities offers insight into how SBA is...

Woodside Energy Group recently reported full-year 2025 results showing sales of US$12.98 billion and net income of US$2.72 billion, alongside record production of 198.8 million barrels of oil equivalent and a final ordinary dividend of US$0.59 per share payable on March 27, 2026. Despite softer commodity prices weighing on profit compared with the prior year, investors are focused on Woodside’s record output, high project completion levels at Scarborough and Louisiana LNG, and the...

BWP Trust (ASX:BWP) has drawn fresh attention after releasing half year results showing higher sales, revenue and net income, together with reaffirmed full year distribution guidance that points to a 4.1% uplift in payouts. See our latest analysis for BWP Trust. These half year results and the reaffirmed distribution guidance come after a period where the share price has been relatively steady. The 1 month share price return was 2.93%, and the 1 year total shareholder return was 16.99%,...

What RLI’s Recent Trading Says About Investor Sentiment RLI Corp (RLI) has been drawing attention after its shares recently closed at US$61.65, with the stock showing a mix of positive short term performance and weaker returns over the past year. See our latest analysis for RLI. Short term momentum has been firmer, with a 1 month share price return of 5.42%. However, the year to date share price return shows a decline of 1.33%, and the 1 year total shareholder return reflects a loss of...

If you are wondering whether Xometry's share price still makes sense after recent swings, you are not alone. This article is going to focus squarely on what you are really paying for in the business. The stock last closed at US$41.82, with a 7 day return of 27.4% decline, a 30 day return of 34.7% decline, a year to date return of 33.4% decline, a 1 year return of 54.8%, and a 3 year return of 127.3%. Recent coverage has highlighted Xometry's position as an online marketplace for...

Third quarter results put U-Haul Holding (UHAL) fleet decisions in focus U-Haul Holding (UHAL) is back on investors’ radar after its 3Q FY2026 update, which combined modest 1.9% revenue growth with pressure on profitability from higher depreciation and losses on retired rental equipment. The self-storage business recorded 7.9% revenue growth, while earnings per share took a reported $0.24 hit from write downs and sales of older vehicles, particularly cargo vans. This has prompted management...

Affiliated Managers Group, Inc. reported higher fourth-quarter and full-year 2025 sales and net income, authorized a new share repurchase program of up to 4,200,000 shares, and declared a US$0.01 per-share cash dividend, while also announcing leadership changes including the planned retirement of director Karen L. Alvingham and the re-appointment of CEO Jay C. Horgen as President, alongside the upcoming departure of President and COO Thomas M. Wojcik. The addition of veteran asset manager G...

Why American Eagle Outfitters (AEO) Is On Investors’ Radar Today American Eagle Outfitters (AEO) has been drawing fresh attention as investors reassess the retailer’s recent share performance, with the stock showing mixed returns across the past week, month, and past 3 months. See our latest analysis for American Eagle Outfitters. At a share price of $24.04, American Eagle Outfitters has seen an 18.66% 90 day share price return, while the 1 year total shareholder return of 85.61% points to...

Why Clearwater Analytics Holdings (CWAN) is back on investors’ radar Clearwater Analytics Holdings (CWAN) has drawn fresh attention after its shares delivered a positive 3 month total return while still showing a loss over the past year, prompting investors to reassess the SaaS provider’s profile. See our latest analysis for Clearwater Analytics Holdings. The recent 8.15% 90 day share price return contrasts with a 1 year total shareholder return loss of 22.5%. Momentum has picked up in the...

Crinetics Pharmaceuticals (CRNX) is back in focus after recent clinical trial results and FDA review acceptance for its lead acromegaly therapy candidate Paltusotine. These developments sharpen attention on the company’s rare disease pipeline. See our latest analysis for Crinetics Pharmaceuticals. Crinetics’ recent trial readouts and the FDA’s acceptance of the Paltusotine filing come after a 30 day share price return of 17.38% decline and a 1 year total shareholder return of 33.30%, which...

What adidas (XTRA:ADS) investors can take from recent performance With no single headline event driving attention to adidas (XTRA:ADS) today, investors are instead weighing the stock’s recent share performance, earnings profile and valuation signals against its longer term track record. See our latest analysis for adidas. At a share price of €158.5, adidas has seen a 7.9% 1 month share price return, while the year to date share price return and 1 year total shareholder return are both...

Xero stock: AI focus and U.S. expansion draw attention after tech volatility Rising interest in Xero (ASX:XRO) has followed sharp swings in Australian tech stocks, as investors weigh AI related risks, inflation pressures, and tariff headlines against the company’s push into AI tools and U.S. accounting plus payments markets. See our latest analysis for Xero. Despite the recent 8.63% 1 day share price return that pushed Xero to A$82.3, momentum has been cooling, with a 30 day share price...

Interparfums (IPAR) has rounded out FY 2025 with fourth quarter revenue of US$386.2 million and basic EPS of US$0.88, alongside trailing twelve month revenue of about US$1.5 billion and EPS of US$5.25. The company has seen quarterly revenue range from US$333.9 million to US$429.6 million across 2025, with basic EPS moving between US$1.32 and US$2.05 earlier in the year before landing at US$0.88 in Q4. This sets up a clear picture of how top line scale and per share earnings have played out...

What PROG Holdings’ Recent Performance Signals for Investors With no single headline event setting the tone, interest in PROG Holdings (PRG) today is largely about how its recent share performance, profitability and size stack up for investors watching the diversified financials space. See our latest analysis for PROG Holdings. Recent momentum has been positive, with a 30 day share price return of 11.28% contributing to a year to date share price return of 26.32%. The 1 year total shareholder...

If you are wondering whether CoreCivic is priced attractively today, this article will walk through how its current share price stacks up against a range of valuation checks. The stock last closed at US$17.17, with recent returns of a 7.5% decline over 7 days, an 8.0% decline over 30 days, a 9.7% decline year to date and a 5.5% decline over 1 year, while the 3 year and 5 year returns stand at 75.0% and 123.9% respectively. Recent coverage of CoreCivic has focused on its role in the U.S...

Lloyds Banking Group (LSE:LLOY) reports new research on UK first-time buyers. Manchester is identified as the leading location outside London for mortgaged first-time home purchases. The findings point to changing patterns in where younger buyers are choosing to purchase homes. Lloyds Banking Group, a major UK retail and commercial bank, is closely tied to trends in mortgages and housing demand. Its latest research on first-time buyers gives investors another datapoint on how younger...

Super Retail Group Limited has reported past half-year results showing sales of A$2,194.7 million and net income of A$104.1 million, alongside declaring a fully franked interim dividend of A$0.32 per share for the six months to December 31, 2025, and appointing Inga Kirkman as an additional Company Secretary effective February 26, 2026. While profit and earnings per share softened compared with the prior year, record sales growth, strong Macpac performance, and a net cash position with no...

If you are wondering whether Kennametal's current share price lines up with its real worth, this article will walk through what the numbers suggest and what that could mean for you. With the stock at US$40.03 and returns of 4.1% over 7 days, 16.2% over 30 days, 38.1% year to date and 85.4% over 1 year, many investors are asking whether the recent performance still leaves room for value or reflects a shift in risk perceptions. Recent company updates and industry headlines have kept attention...

Why Xylem’s new buyback is on investors’ radar Xylem (XYL) has drawn fresh attention after its Board authorized a share repurchase program of up to US$1.5b, with no expiration date. This type of move is one many investors watch closely. See our latest analysis for Xylem. At a share price of US$128.26, Xylem has a 30 day share price return of 10.53% decline and a year to date share price return of 6.45% decline. Its 1 year total shareholder return of 1.04% versus a 31.54% total shareholder...

Viking Therapeutics has completed enrollment in its Phase 3 VANQUISH-1 trial of VK2735, a dual GLP-1 and GIP receptor agonist for obesity. The company is advancing both injectable and oral formulations of VK2735 into late-stage clinical trials. Reduced competition following a rival's clinical setback has increased attention on Viking as a potential acquisition target. Viking Therapeutics, traded as NasdaqCM:VKTX, is drawing fresh interest after reaching full enrollment in its Phase 3...